Close Menu

Keith Robison has a post on his Omics! Omics! blog about Roche's seemingly unquenchable thirst for acquisition targets. Robison recaps the recent acquisitions of 454 and NimbleGen, as well as the company's currently-in-play bid for Ventana, and ponders how these units could function together as well as what kind of technology might be next on Roche's shopping list.

 

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

NPR says the explosion and fire earlier this week at a Russian lab that stores dangerous pathogens revives the question of whether such samples should be kept.

According to Wired, Nebula Genomics is providing a way for people to get their genomes sequenced anonymously.

A 26-year-old woman tells Cosmopolitan about learning her APOE status at a young age.

In Science journals this week: a functional genomic screen uncovers drug combination that increases KRAS inhibitor efficacy in aggressive lung cancer, and more.